BNP Paribas Financial Markets’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.62M | Buy |
|
|||||
|
2025
Q2 | $987K | Buy |
|
|||||
|
2025
Q1 | $800K | Sell |
|
|||||
|
2024
Q4 | $1.22M | Sell |
|
|||||
|
2024
Q3 | $1.9M | Buy |
|
|||||
|
2024
Q2 | $429K | Sell |
|
|||||
|
2024
Q1 | $2.99M | Sell |
|
|||||
|
2023
Q4 | $4.85M | Buy |
|
|||||
|
2023
Q3 | $3.37M | Buy |
|
|||||
|
2023
Q2 | $1.76M | Sell |
|
|||||
|
2023
Q1 | $2.03M | Buy |
|
|||||
|
2022
Q4 | $1.01M | Sell |
|
|||||
|
2022
Q3 | $1.53M | Buy |
|
|||||
|
2022
Q2 | $301K | Buy |
|
|||||
|
2022
Q1 | $156K | Sell |
|
|||||
|
2021
Q4 | $384K | Buy |
|
|||||
|
2021
Q3 | $205K | Buy |
|
|||||
|
2021
Q2 | $49.4K | Sell |
|
|||||
|
2021
Q1 | $149K | Buy |
|
|||||
|
2020
Q4 | $115K | Sell |
|
|||||
|
2020
Q3 | $139K | Buy |
|
|||||
|
2020
Q2 | $64.1K | Sell |
|
|||||
|
2020
Q1 | $237K | Buy |
|
|||||
|
2019
Q4 | $68.1K | Sell |
|
|||||
|
2019
Q3 | $45.8K | Buy |
|
|||||
|
2019
Q2 | $2.21K | Buy |
|